192
An immune antibody-cleaving drug from Hansa Biopharma could soon make it easier for some patients to get kidney transplants in the US.
The Swedish biotech …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.